Dr. Charles W. Heiling is a Professor in the Department of Medicine, University of Florida, USA

Roles for glucose transporters in diabetic kidney disease and in the progression of chronic glomerular disease

Dr. Rao M. Uppu is a Professor of Environmental Toxicology in Southern University and A & M College

His research focuses on Water-soluble Fatty Acid Criegee Ozonides,1,3-Butadiene and Ozone Interactions in Urban Environments, Nitric Oxide-derived Oxidants and Xenobiotic Metabolism, Environmental Decontamination of Sodium Azide

Dr. Patrick Nelson is an Assistant Professor in Department of Computational Medicine and Bioinformatics in the  University of Michigan, USA

Clinical Informatics
Databases and Computing
Modeling Immunological and Infectious Disease Systems
Statistical Applications
Systemic Modeling and Systems Biology

Dr. Zhengyuan Xia is an Assistant Professor and Honorary Associate Professor in Department of Anesthesiology, and Research Centre of Heart, Brian, Hormone and Healthy Aging, University of Hong Kong. He has received PhD in Pharmacology & Therapeutics from University of British Columbia (UBC), Canada in 2004, and completed postdoctoral training respectively in the Faculty of Pharmaceutical Sciences, UBC, and Department of Pharmacology & Therapeutics, University of Calgary 2004-2007. He received his M.B. (medical doctoral program) and Master of Medicine degrees respectively in 1984 and 1991 from China, and worked as an anesthetist before starting PhD study in 2001. He has published more than 58 articles [PubMed: “zhengyuan xia or zheng-yuan xia”] in internationally reputed journals. He is a frequent reviewer for reputed journals like Biochemical Pharmacology, PLOS One, and Anesthesiology , and for grants agencies like NSFC (National Natural Science Foundation of China) and CIHR (Canadian Institute of Health Research).  
 

My overall research interest is the protection of myocardial ischemia-reperfusion injury (IRI), particularly, of diabetic hearts.
 

Professor Shahzad is currently affiliated with University of Vienna, Austria. Professor Shahzad is one of the pioneers, working for the progress of translational medicine field. He is serving as a secretary general and director of administration for “international society for translational medicine (ISTM)” He is serving as visiting professor of translational medicine, at the First Affiliated Hospital, Harbin Medical University, Harbin, China. He is also appointed as associate professor of translational medicine (Adj), at the First Affiliated Hospital, Wenzhou Medical College, China. Professor Shahzad has won many prestigious international fellowships and awards. Professor Shahzad is invited speaker for many international life sciences conferences.

Translational Research and Clinical Diagnostics

Dr. Helmy M. Siragy is a Professor of Medicine and Endocrinology, University of Virginia Health System, USA

Biology and Pathophysiology of Angiotensin Receptor Subtypes in the Kidney and Heart Diseases

Dr. William D. Eldred received his PhD in Anatomy from the University of Colorado Health Sciences Center in 1979. Currently at Boston University, he is a Professor in the Biology department, the Graduate Program in Neuroscience, and the Program in Molecular Biology, Cell Biology and Biochemistry; and he is a Research Fellow in Department of Cognitive and Neural Systems. From 2002-2010 Dr. Eldred was the Director of the graduate Program in Neuroscience at Boston University. He is serving as an editorial board member for the Open Journal of Nitric Oxide and the Journal of Experimental Pharmacology. He is a long time member of the Society for Neuroscience and the Association for Research in Vision and Ophthalmology. He has been honored with an International Human Frontier Science Program Organization Fellowship and he has been an Alexander von Humboldt Foundation Research Fellow and a Visiting Scholar at the Vision Science Research Center at the University of Alabama in Birmingham.

 

Dr. Eldred′s research for the past 15 years has examined the role of the gaseous neuromodulator nitric oxide (NO) in retinal signal transduction and ocular pathology. He has determined that nitric oxide is reciprocally related to many retinal neurotransmitters including GABA, glycine, acetylcholine, and dopamine in that NO modulates their release and they in turn modulate NO production. He has also shown that every cell type in the retina can produce NO. Using direct imaging of NO, he established that in retina NO is not freely diffusible. He is now examining the role that NO plays in the early neuronal cell death seen in diabetic retinopathy by focusing on the role that the signaling peptide adrenomedullin plays in producing the pathological increases in NO found in early diabetic retinopathy. He has established and localized all of the biochemical steps in this pathway and is now developing pharmacological interventions to inhibit the pathological activation of the adrenomedullin/NO signaling pathway. Since both NO and adrenomedullin are involved in much ocular pathology including glaucoma, ischemia, and uveitis, a better understanding of the adrenomedullin/NO signaling pathways will have broad clinical applicability.

Kowluru Anjan is a Professor in the Department of Pharmaceutical Sciences, Wayne State University, USA.

Diabetes, health disparity, obesity, hypertension, osteoporosis. Bone cell biology, cell cycles, parathyroid hormone receptor, stress response, hypothalamic-pituitary-adrenal axis, corticotropin releasing factor receptors and urocortins, insulin signaling, adiponectin receptors, insulin secretion Regulation of energy substrate metabolism, gene expression and signal transduction in the heart.

Heinrich Taegtmeyer is Professor of Medicine, University of Texas Houston Medical School, Houston, Texas.  Dr. Taegtmeyer received his Dr. Med., from the University of Freiburg in 1970, and his DPhil in Biochemistry from the University of Oxford in 1981.  His research interests are regulation of energy substrate metabolism, gene expression and signal transduction in the heart. 

Regulation of energy substrate metabolism, gene expression and signal transduction in the heart

 Kenneth Maiese is Professor and Chair of Neurology and Neurosciences of the University of Medicine & Dentistry of New Jersey. Dr. Maiese has been fortunate to receive recognition with outstanding teaching awards and election to America′s Top Physicians, the Best of U.S. Physicians, and Top Doctors. His investigations are designed to translate basic science into successful therapeutic treatments for conditions such as cancer, metabolic disorders, cardiovascular disease, diabetes, stroke, and Alzheimer&prime:s disease. He is a top cited author with continuous funding from the American Diabetes Association, the American Heart Association, the Bugher Foundation, a Johnson and Johnson Focused Giving Award, and the NIH. Dr. Maiese holds several patents, has over 250 publications and has authored 5 books. Dr. Maiese also serves as the Editor-in-Chief, Associate Editor, or editorial board member for more than 40 journals as well as on multiple executive committees, technology panels, and scientific advisory councils.

Cancer, metabolic disorders, cardiovascular disease, diabetes, stroke, and Alzheimers disease

Masayoshi Yamaguchi　is visiting professor in Division of Endocrinology and Metabolism and Lipids, Department of Medicine, Emory University School of Medicine (2007~ Present), professor in Laboratory of Endocrinology and Molecular Metabolism, Graduate School of Nutritional Sciences, University of Shizuoka, Japan (1993 ~ August 2007), associate professor in Graduate School of Nutritional Sciences, University of Shizuoka, Japan (1991~1993), assistant professor in School of Pharmaceutical Sciences, University of Shizuoka, Japan (1987~1991), visiting assistant professor in University of Texas School of Medicine, Huston, USA (1988), assistant professor in Shizuoka College of Pharmacy, Japan (1986~1987); visiting assistant professor in Texas Tech University School of Medicine, USA (1985); visiting lecturer in University of Pennsylvania School of Medicine, USA (1981), research associate in Shizuoka College of Pharmacy, Japan (1973 ~ 1986). He received a Ph.D. in Pharmaceutical Sciences from Shizuoka College of Pharmacy (1976, Japan), He has completed his B.A in Pharmaceutical Sciences, Shizuoka, Japan (1971).

   He received many honor and awards; Prize for Sato Memorial Fundation (1992, Japan/USA), Senji Miyata Foundation Award 2005 (Japan), Japan Society for Biomedical Research on Trace Elements Award 2007, The Lifetime Achievement Award from International Biographical Centre (IBC) (2004, England), The World Lifetime Achievement Award from American Biographical Instritute (2004, USA), The Distinguished Service to Science Award from IBC (2007, England) and others. He is listed in various biographies; Who’sWho in the World (2005-, Marquis Who’sWho, USA), Who’sWho in Sciences and Engineering (2004-, Marquis Who’sWho , USA), International Biographical Dictionary (2006-, IBC, England)  and others.
 

His research interest is in the fields of endocrinology and metabolism for bone and calcium since 1971 years, and it has been developed in the aspects of endocrinology, biochemistry, nutrition, pharmacology and toxicology. Especially, he has an interesting for bone biology, osteoporosis prevention by nutritional factors, diabetic osteoporosis and intracellular signaling mechanism. He discovered two novel proteins and genes; the named regucalcin, a regulatory protein in intracellular signaling system, and RGPR-p117, a transcription factor. Regucalcin transgenic rats are generated and this rat has been known to induce osteoporosis and hyperlipidemia.

Daria Mochly-Rosen is a Professor in the Stanford University School of Medicine, USA

Wilbert S. Aronow, MD is Clinical Professor of Medicine at New York Medical College. He has edited 8 books and is author or coauthor of 1,180 papers 163 Letters to the Editor, commentaries, or book reviews, and 846 abstracts. He has given 1,167 talks at meetings. Dr. Aronow has been a member of 54 editorial boards of medical journals, an associate editor for 5 medical journals, a guest editor for 6 other medical journals, and has reviewed manuscripts for 193 medical journals.  He has been a consultant to numerous government agencies and a member of committees in numerous professional societies. He has received numerous awards including the Walter Bliefeld Memorial Award for distinguished contributions to clinical research from the International Academy of Cardiology at the 15th World Congress on Heart Disease in 2010.
 

Cardiovascular Disease

Anna C. Phillips is a professor at the School of Sport and Exercise Sciences, University of Birmingham, UK. Behavioural Scientist, Health Psychologis and Admissions Tutor. She has received a PhD in Psychoneuroimmunology from the University of Birmingham, UK, 2002-2005. She won the University Ratcliffe Prize for the best PhD in Life Sciences that year. She has received an M.Sc. with distinction in Health Psychology from Staffordshire University, UK, 2002. She has completed her B.Sc. in Psychology at the University of Birmingham, UK, 1998. She received the Herbert Weiner Early Career Award from the American Psychosomatic Society, 2010. She received the Neal Miller Early Career Award from the Academy of Behavioral Medicine Research, 2010. She is serving as an editorial board member of a reputed journal and reviewer for 22 journals. She currently has over 60 peer-reviewed publications

Behavioural Medicine, Health Psychology Cardiovascular Psychophysiology, Social Epidemiology, Stress and effects on Immune function, Cardiovascular reactivity to acute stress implications for health, Physical and psychological trauma in older age effects on immunity, Stress hormones and physical frailty in older age, Chronic stress and the interaction with ageing - effects on immunity, physical frailty, and cognition

Professor Zhaoqian Liu, is currently the vice deans of both Institutions of Clinical Pharmacology and Xiangya Medical Laboratory at Central South University, and also director of Hunan Key Laboratory of Pharmacogenetics. He has been the senior visiting Scholar at Munich University in Germany from 1996-1998, and the Postdoctoral Research Fellow at Department of Toxicology and Pharmacology of Indiana University in United State of America from 2002-2004. Professor Liu has got more than 32 national and province grants and published 65 SCI papers on pharmacogenetics and pharmacogenomics published in abroad journals such as Nucleic Acids Research, Clinical Pharmacol Ther, and Clinical Cancer Research and so on. He has obtained 5 national invention patents.
 

Professor Liu is now focusing on the research of basic and clinical applications of Pharmacogenetics and pharmacogenomics on major diseases such as diabetes, hypertension and malignant tumor.


 

Sergei V. Pereverzev is Professor and Research supervisor in Research Group "Inverse Problems" of the Johann Radon Institute for Computational and Applied Mathematics. He is a co-developer of the fully adaptive regularized learning (FARL) methodology for predicting blood glucose concentration and the prediction-error grid analysis (PRED-EGA) for the assessment of glucose predictors. He is also the author of over one hundred scholarly articles and serves as a member of editorial boards of 5 journals.
 

His area of expertise includes, in particular, data-based  modeling and prediction of blood glucose dynamics.
 

Hiroyuki Koshiyama is a Professor in the Department of Diabetes & Clinical Nutrition, Graduate School of Medicine, Kyoto University, Japan

Diabetes and Metabolism

Yong X Wang is Head of Kingrsquo′s Lab and Professor of Biotechnology and Pharmacology at Shanghai Jiao Tong University School of Pharmacy, Shanghai, China. He received a PhD in Pharmacology from The University of British Columbia, Canada in 1994 followed by postdoctoral training in the field of Clinical Pharmacology at Stanford University, USA. He completed his B.Sc in Medicine from Anhui Medical University. China, in 1982. He has published more than 50 peer reviewed papers and reviews in reputed journals as well as several patents. He is frequently invited to present at domestic and international scientific conferences and serves on a number of professional society committees and editorial boards of reputed journals.

Translational Pharmacology in the areas of pain, cancers and metabolic diseases including diabetes and obesity, discovery and development of novel drugs for the treatment of type II diabetes mellitus, DNA methylation gene silencing technology.

Geoffrey Burnstock is President of the Autonomic Neuroscience Centre, University College Medical School, UK. Completed his PhD at UCL, became Professor and Chairman of Zoology, Melbourne University (1964), Head of Department of Anatomy and Developmental Biology at UCL (1975) and Director of the Autonomic Neuroscience Institute (1997). Elected to the Australian Academy of Sciences (1971), Royal Society (1986), Academy of Medical Sciences (1998) and Honorary Fellow of the Royal College of Surgeons (1999) and Physicians (2000) and awarded the Royal Society Gold Medal (2000) and 2010 Gaddum Memorial Award. He is Editor-in-Chief of Autonomic Neuroscience (Elsevier), Purinergic Signalling (Springer) and Open Neuroscience and Open Pharmacology Journals (Bentham). He has supervised over 100 PhD and MD students and has published over 1,400 papers, reviews and books. He is the most cited scientist in Pharmacology and Toxicology since 1994.

His major research interest stems from his seminal discovery of purinergic signalling.

Herbert Michael Heise is Honorary Professor at the University of Applied Sciences of South-Westphalia, Iserlohn and a Senior Scientist at Leibniz-Institute for Analytical Sciences ISAS at Dortmund University of Technology, Germany. Research Fellow at the German National Physical Laboratory (PTB) (1979-1982) and the Federal Biological Research Centre (1977), both in Braunschweig, Germany. Research associate at School of Chemistry, The University of Western Australia, Perth (1976 / 1978-79) and Institute of Physical Chemistry of Christian-Albrechts-University in Kiel, Germany (1974-1976 / 1978) He has received a PhD in Physical Chemistry (1976), completed his Diploma Degree in Chemistry (M.Sc., 1972) and received a B.Sc. equivalent degree in mathematics (1974) from Kiel University. Gledden Visiting Senior Fellow at The University of Western Australia (2003). Honorary Fellow of the Association of Biotechnology and Pharmacy (2009). He is serving as a member of the editorial board of Vibrational Spectroscopy and Current Trends in Biotechnology and Pharmacy ; he is reviewer of more than 5 other journals in the area of analytical chemistry and spectroscopy. He is co-author of two textbooks and of 180 publications including contributions to book chapters and encyclopedias.

Mario Barbagallo, is full Professor of Geriatrics, Director of the Geriatric Unit, University Hospital of Palermo, Director, Post-graduate program in Geriatrics, University of Palermo, Italy. He was born on March 16, 1959, in Palermo, Italy. In 1989 received a Ph.D in Physiology, University of Rome. Research Associate, Cardiovascular Center,  Cornell University Medical Center, New York, NY, USA in 1991-1992, and Visiting Professor and Fulbright Scholar, Division of Endocrinology and Hypertension, Wayne State University, Detroit, MI, USA in 1994-1995. Full Professor of Geriatric Medicine, at the University of Palermo from 2000. He is serving as Editor in Chief of “Giornale di Gerontologia” and Associate Editor of “Aging- Clinical and experimental Research”.  Member of the editorial board of other reputed journals. Has peer reviewed more than 200 papers from several international journals. Author of more than 300 publications.

Aging, Magnesium/calcium metabolism with aging, Hypertension in the elderly, Osteoporosis, Dementia.Stephan Christopher Collins is a senior scientist working at the Oxford Centre for Diabetes, Metabolism and Endocrinology (OCDEM, oxford University). He was the recipient of a Wellcome Trust Prize studentship for his PhD which he endeavoured at Oxford University in the field of genetics and Type 2 Diabetes (T2D). After a two-years post doctoral position at the Sanger Institute (Cambridge), he joined the laboratory of Professor Patrik Rorsman in 2005. Models of beta cell dysfunction Lipotoxicity and diabetes Obesity and diabetes.
 

Juan Francisco is a Professor in the School of Health and Social Services of the Canary Islands

Diabetes and Metabolism

Yellela Sri Rama Krishnaiah is an Associate Professor in Pharmaceutical Sciences in Nova Southeastern University, Florida, USA

Judith Aponte is a Specialization Coordinator of the Community/Public Health Nursing (MS) Program and of the Community/Public Health Nursing/Urban Public Health (MS/MPH) Graduate Program, Hunter-Bellevue School of Nursing, Hunter College, City University of New York, Associate Professor, HBSON, Hunter College, CUNY. Dr. Aponte received a DNSc in Nursing from Columbia  University, 2004. She completed her MSN in Nursing Administration in 1998 and her BSN in 1994 from HBSON, NY. She has reviewed manuscripts of peer-reviewed journals on topics related to diabetes. Dr. Aponte has numerous publications, international presentations, and has conducted research on diabetes and its risk factors, specifically as it affects the Hispanic population.  She is one of the few US researchers whose work has acknowledged Hispanics as a heterogeneous, not homogeneous, group, and diabetes-related issues that affect different Hispanic subgroups.
 

Diabetes and Diabetes-related Risk Factors
Hispanic Subgroups
Community Health Nursing
Public Health Nursing
Technology in the Nursing Curriculum
Nursing Education
 

Dharambir K. Sanghera is an Associate Professor in the University of Oklahoma Health Sciences Center, USA

Pediatrics, Molecular Genetic Epidemiology

Pandu R. Gangula is an Associate Professor in the Department of Obstetrics / Gynecology, Center for Women’s Health Research (CWHR), Meharry Medical College, Nashville, Tennessee, USA. He has received a PhD in Zoology from the S.V University, Andhra Pradesh, India in, 1986-1992. He has completed his B.Sc in biology in Andhra University, Andhrapradesh, India (1984). He is serving as reviewer for several journals. Publications: Dr. Gangula has been a highly productive investigator with over 40 refereed publications since 1991. In the last 12 years, thirty of these publications have been related to nitric oxide, neuropeptide and/or sex hormone action on vascular, uterine and gastric smooth muscle relaxation; most of these appear in high ranking physiology and endocrinology journals.

Gender bias in diabetic gastroparesis
Fetal Programming and adult disease
Cardiovascular diseases in aged women
Preeclampisa
 

Dr. Naila Rabbani graduated with a B.Sc in Biological and Medicinal Chemistry in 1998 and PhD in Disease Mechanisms and Therapeutics in 2001 at the University of Essex, Colchester, UK. She pursued pre-doctoral research improving analytical methods to identify and quantify markers of protein damage by glycation and has maintained an interest in protein glycation in disease mechanisms and therapeutics. She received Shaul Massry Prize for the best oral presentation at the 4th International Congress on Uremic Research and Toxicity in 2005. She was awarded a British Heart Foundation Intermediate Fellowship in 2006 for research on glycation of lipoproteins and became an assistant Professor in Experimental Systems Biology at the University of Warwick in 2007 and promoted to Associate Professor in 2010. She is Co-director – with Professor Paul J Thornalley - of the Protein Damage and Systems Biology Research Group, Warwick Medical School. She employs “gold standard” stable isotopic dilution analysis mass spectrometry for comprehensive and quantitatively screening of amino acids and related glycated, oxidised and nitrated derivatives in mammalian cell culture, pre-clinical animal pharmacology and clinical studies – including working with several national and international collaborating research groups. She has over 50 publications in peer-reviewed journals and more than 65 abstracts/conference papers.

 Her current research focuses on investigations of damage to lipoproteins and influence of dietary bioactive compounds on lipoprotein synthesis, damage and metabolism - supported by the BHF and BBSRC.

Kannayiram Alagiakrishnan is an  Associate Professor in the Department of Medicine, University of Alberta, Canada

Hidenori Koyama is an Associate Professor in the Department of Metabolism, Endocrinology and Molecular Medicine, Osaka City University, Graduate School of Medicine, Japan

Metabolism, Endocrinology and Molecular Medicine

Sarah X. Wang is an Assistant Professor in the section of Endocrinology and Diabetes, OU Health Sciences Center, USA

Diabetes & Endocrinology

Dong Hyun Kim is a assistant professor in the Department of Physiology and Pharmacology, University of Toledo. He has received a PhD in Biochemistry from Korea University, Korea, 2002-2006. He has completed his BA in Biomedical Science in New Hallym University, Korea, 1995. He is serving as an editorial board member of reputed journals and reviewer of 2 journals

Adult Stem Cells from Human Bone Marrow, Cord Blood, Fat tissues and other tissues. Mesenchymal Stem Cells (MSCs) and Hematopoietic Stem Cells (HSCs) for therapeutic resources Adipogenesis of MSCs from human bone marrow. hypertension, stroke, diabetes and obesity, the role of oxidative stress HO-1, heme oxygenase, the most potent anti-oxidant gene in human body.

Dr. Fabrizio Grosjean is an Assistant Professor in the Division of Experimental Diabetes and Aging, Mount Sinai School of Medicine, USA

Diabetic nephropathy and advanced glycation end products. Mechanism of damage and repair in kidney ischemia reperfusion injury Mechanism involved in glomerular and tubulointerstitial extracelullar matrix deposition Cardiovascular risk in kidney transplanted patients

Joseph A Baur is an Assistant Professor in the Institute for Diabetes Obesity and Metabolism and the Department of Physiology at the University of Pennsylvania School of Medicine. He received his PhD from the University of Texas Southwestern Medical Center in Dallas Texas 1998-2003. He completed his BScH in Chemistry at Acadia University in Wolfville Nova Scotia Canada in 1998. He currently serves as an editorial board member for the Journals of Gerontology and is a frequent reviewer for many reputed journals including the Journal of Clinical Investigation Diabetes and Mechanisms of Aging and Development

Aging Sirtuin enzymes, Caloric restriction, Mitochondrial Metabolism and energy balance.

Qiaoming Long is an Assistant Professor of Molecular Physiology in the Department of Animal Science Cornell University. He received a PhD in Molecular Biology from University of Edinburgh Scotland United Kingdom in 1996. He completed postdoctoral trainings in Developmental Biology at Medical College of Georgia and University of Ottawa between 1996 and 2001. He is currently a member of the American Diabetes Association and the International Society of Stem Cell Research

Transcriptional control of pancreatic development and function Endoplasmic reticulum stress and the unfolded protein response Protein quality control in pancreatic beta cells and type 2 diabetes Protein quality control and obesity-induced insulin resistance ER protein quality control and autophagy cross-talk Endoplasmic reticulum chaperones and type 2 diabetes Protein quality control and neurodegenerative diseases.

Shuxia Wang is an Assistant Professor of Graduate Center for Nutritional Sciences at University of Kentucky. She has received her PhD in Physiology from Peking Union Medical College in China in 1997. She has completed her MD from Shanxi Medical University in China in 1991. She has completed her postdoctoral training in the Department of Pathology at University of Alabama at Birmingham 2000-2004. She received Postdoctoral Development Award from University of Alabama at Birmingham, Scientist Development Award from American Heart Association, Travel Award from American Society of Nephrology and Wethington Award from University of Kentucky. She is an active grant reviewer for American Heart Association and also a reviewer for many journals

Diabetic nephropathy Renal ischemia-reperfusion injury Cardiovascular disease Obesity and insulin resistance.

Rene Oliveros is an Assistant Professor in the UT Health Science Center, USA

Cardiovascular Diseases

Khalid Matrougui is an Assistant Professor in the Tulane University, USA

Type 2 diabetes, hypertension, inflammation, angiogenesis, vascular function & structural remodeling, growth factors, oxidative stress, in vivo & in vitro signaling

Mark T. Marino is a Senior Vice President in the Research and Exploratory Medicine, MannKind Corporation, New Jersey, USA

Susanna Hofmann is an Assistant Professor in the Department of Internal Medicine, University of Cincinnati College of Medicine, USA

David D. Schwartz is a Neuropsychologist at Texas Children’s Hospital, where he coordinates the Pediatric Health Psychology Program, and Assistant Professor of Pediatrics at Baylor College of Medicine. He completed a postdoctoral fellowship in Neuropsychology at Texas Children’s Hospital/Baylor College of Medicine in 2006. He received his PhD in Psychology from the University of Delaware in 2004.

Medical Adherence in Youth with Type 1 Diabetes
Executive Functioning and Adherence
Psychosocial Screening and Preventive Intervention in Pediatric Chronic Illness
Neurocognitive Outcomes in Pediatric Chronic Illness
ADHD and Pediatric Chronic Illness
Family Functioning in Response to Pediatric Chronic Illness
Psychosocial Outcomes in Pediatric Kidney Transplant
Neurocognitive Functioning of Individuals with Costello Syndrome
 

Dr YoungMi Go received PhD in Pathology from the University of Alabama at Birmingham She joined the Department of Biochemistry in the Emory University Atlanta GA for her postdoctoral training Currently she is Assistant Professor in the Department of Medicine Division of Pulmonary Allergy and Critical Care Medicine in the Emory University She has authored 26 peer reviewed research articles 2 book chapters and 5 reviews

During her doctoral study she identified the signaling mechanisms of laminar shear stress-protected vascular disease, atherosclerosis development. During her first post-doctoral training at UAB, her research focused on defining mechanisms for oxidized low density lipoprotein-stimulated early event of atherosclerosis. Her research focused on investigating thiol/disulfide redox system and reactive oxygen/nitrogen species-controlled signaling mechanisms in association with atherosclerosis development. During the last several years she has developed a new technique for redox proteomics by redox ICAT analysis combined with mass spectrometry, which identifies redox-sensitive proteins and their associated mechanisms. Her current research focuses on identification of extracellular redox-regulated endothelial cellular function by examining mechanisms implicated in cardiovascular diseases

Dr. Paras Kumar Mishra is an Assistant Professor in the Department of Physiology & Biophysics, University of Louisville, USA

Dr YuLong Li is an Assistant Professor in Department of Emergency Medicine and also is a Courtesy Assistant Professor in Department of Cellular Integrative Physiology at the University of Nebraska Medical Center, USA. He received his MD at Hebei Medical University in 1984 and his PhD in Physiology from Hebei Medical University China in 1994. He has published over 50 research papers in the most highly regarded journals. His research has been funded by the National Institutes of Health and the American Heart Association. He is serving as reviewer for several journals like Hypertension Cardiovascular Research and the American Journal of Physiology. He is a member of the American Physiological Society and the American Heart Association. He received Research Recognition Award from the American Physiological Society

Neural control of the cardiovascular function in type-I and type-II diabetes Skeletal muscle and cardiac ischemia-reperfusion injury Mitochondrial dysfunction and reactive oxygen species in pathological states Baroreflex dysfunction in chronic heart failure

Dr. Ippei Kanazawa is an Assistant professor of Medicine in the Division of Internal Medicine, Shimane University Faculty of Medicine. He has received a PhD in Medical Science from Shimane University Graduate School of Medicine, Izumo, Shimane, Japan in 2009. He received “Research exhortation award” from Japanese Society of Osteoporosis and “Plenary research award” from Japanese Society of Endocrinology in 2007 and “Academic exhortation award” from Japanese Society of Osteoporosis and “Asia travel award” from Japanese Society of Bone and Mineral Research in 2006.

Association between adipocytokines and bone metabolism
Atherosclerosis in diabetes mellitus
Bone metabolism in diabetes mellitus

Dr. Maoqing Dong is an Associate Professor of Medicine in Mayo Clinic College of Medicine, USA

Diabetes and metabolism

Dr. Sanjay Kapur is the Director of ZRT Laboratory, Beaverton, USA

Dr. Wayman Wendell Cheatham is the Director of Navy Medicine RD Center; Director, Clinical Investigation Programs, USA

Diabetes and metabolism, Clinical Investigations

Dr Gragnoli Claudia is an MD/PhD endocrinologist who has been working in the genetics of maturityonset diabetes of the young and type 2 diabetes mostly in the Italian population. She graduated in Medicine and Surgery and became an Endocrinologist at the U La Sapienza of Rome. She performed her research at U La Sapienza at the U of Chicago as JDFI Fellow at the U Tor Vergata where she obtained her PhD in Clinical and Preventive Nutrition and at Harvard Medical School and Mass General Hospital where she was Instructor International Rotary Ambassador NIH Training Fellow and has been teaching/tutoring Human Genetics of Complex Disorders/Endocrinology/Chemistry and Cell Biology Currently she is the Director of the Laboratory of Molecular Genetics of Monogenic and Complex Disorders at Penn State Milton S Hershey Medical Center and holds a tenuretrack position as Assistant Professor in Medicine Cellular amp; Molecular Physiology and Biostatistics at Penn State University College of Medicine Dr Gragnoli is member of the Faculty Committee of the Penn State University PhD Programs Dr Gragnoli holds a Joint Associate Professor appointment in Biology at Temple University′s College of Science and Technology Philadelphia PA

Genetics of Complex Disorders

Dr. Arvinder Dhalla is currently the Director of Biology in Cardiovascular Therapeutic Area at Gilead Sciences and leads the CardioMetabolic group. She completed her PhD degree in cardiovascular physiology from St. Boniface Institute of Cardiovascular Sciences at University of Manitoba Canada in 1994. Arvinder did her postdoctoral training at the University of Missouri, Columbia. Arvinder worked as a scientist and senior scientist and project leader at CV Therapeutics from 2001-2008. Arvinder has published 40 papers in peer reviewed journals and has served as a reviewer for various journals. She is a member of several professional societies including American Heart Association and American Diabetes association

A1 adenosine receptor agonists as anti-lipolytic agents. Role of adipose tissue lipolysis and FFA in insulin resistance and diabetes. Role of Late Ina in ischemia and heart failure. Role of oxidative stress and anti-oxidants in transition of hypertrophy and heart failure. Role and regulation of extracellular matrix in hypertrophy and heart failure.

Yang Li, is a Scientific Director in the Metabolic Disorders Therapeutic Area at Amgen, South San Francisco, CA.  He received his Ph.D from the Department of Cell Biology, Stanford University, CA in Dr. Roger Kornberg’s laboratory.  Yang completed his B.S degrees in Chemistry and Molecular and Cellular Biology from Pennsylvania State University, PA.  Yang served as ad hoc reviewer for several journals, he has over 40 published manuscripts/book chapters and 12 issued patents or patent applications.

Dr. Mohamad Navab has received his PhD in Biochemistry from NY Columbia University during the period of 1970 to 1976. Currently, Dr. Navab is working as Professor of Medicine/Cardiology in UCLA University. He has successfully completed his Administrative responsibilities as Project Leader. He is serving as an editorial member of several reputed journals. He has authored 160 research articles/books. He is a member of American Heart Association. He has been honored as a recipient of NIH post Doctoral Awards 

HDL, mimetic peptides

Head Section of Clinical Biochemistry, Cleveland Clinic, USA

Clinical Pathology

Adam Whaley-Connell is an Assistant Professor of Medicine at the University of Missouri-Columbia School of Medicine in the Department of Internal Medicine, Division of Nephrology and Hypertension. He is a Staff Physician at the Harry S Truman VA Medical Center in Columbia.  He received his B.S from Truman State University in 1996 and his DO from the Kansas City University of Medicine and Biosciences in 2001.  He then went on to complete a Internal Medicine residency at the University of Missouri-Columbia School of Medicine in 2004.  This was followed by combined nephrology and family and community medicine research fellowship in the Diabetes and Cardiovascular Center.   Dr. Whaley-Connell has received the Young Alumni Achievement Award from KCUMB, the Young Scholar Award from the American Society of Hypertension and the University of Missouri Provost′s Outstanding Research and Creativity Award.  He has published over 100 peer reviewed manuscripts and serves on 5 editorial boards as well as ad-hoc reviewing for numerous other biomedical journals.

Diabetes and Hypertension in those with Chronic Kidney Disease as they relate to Cardiovascular Disease

Dr. Mbaezue N is an Assistant Professorin the Department of Medicine, Morehouse School of Medicine, USA

Diabetes and metabolism

Endocrinology Service, Wilford Hall Medical Center, USA

Endocrinology and Metabolism

President and Chief Science Officer, Provident Clinical Research, USA

Diabetes and Metabolism

Oxford Centre for Diabetes, Endocrinology and Metabolism, Oxford University, The Churchill Hospital, Headington Oxford, USA

Endocrinology and Metabolism

Takeshi Kinoshita has completed his from Tottori University in 2004. He worked with NTT Medical Center Tokyo during 2004 and 2006, Residency in Cardiovascular Surgery, Shiga University of Medical Science between 2006 and 2009. Presently he is an Assistant Professor of Cardiovascular Surgery, Shiga University of Medical Science.
 

Off-pump coronary artery bypass surgery
Mitral valve repair
Clinical and basic research on arterial grafts and postoperative atrial fibrillation
 

Director of the Coronary Care Unit, University Hospital of Geneva, Switzerland

Diabetes and Metabolism

Subir K. Roy Chowdhury is a Research Scientist at the St. Boniface Hospital Research Centre which is affiliated with the University of Manitoba, Winnipeg, Manitoba, Canada. He has received his Ph.D in Biochemistry and Pathobiochemistry focused on inherited mitochondrial metabolic diseases from Charles University, Prague, Czech Republic (1997-2002). He has completed MD at the First Faculty of Medicine, Charles University, Prague (1997). He has received two years Postdoctoral Fellowship from U.S Army at McMaster University, Hamilton, Ontario, Canada. He has published his scientific work in reputed journals. He is a Biochemist and Mitochondrial Research Scientist with the research related in Diabetes, Cardiovascular Diseases, Cancer, Inherited Mitochondrial Disorders, Neuromuscular, and Neurodegenerative Diseases.

Diabetes, Cardiovascular Diseases, Cancer, Inherited Mitochondrial Disorders, Neuromuscular and Neurodegenerative Diseases.

Research Director, INSERM, Institut Pasteur de Lille and University of Lille2, France

Diabetes and Metabolism

Diana Rubin, Gastroenterology and Nutrition Medical University Hospital, Germany

Nutrition, Diabetes and metabolism

Fabio Angeli is a cardiologist and a biomedical researcher of the Department of Cardiology and Clinical Research Unit, Preventive Cardiology, Perugia, Italy. Fellow of the Associazione Nazionale Medici Cardiologi Ospedaliari (ANMCO) and member of several scientific societies.

Cardiovascular risk assessment in patients with hypertension, diabetes, heart failure and coronary artery disease. Evaluation of cardiovascular treatment. Diagnosis and treatment of acute myocardial infarction. Author of scientific works on cardiovascular disease, diabetes and hypertension published in leading journals. Reviewer for several leading medical journals. Investigator and co-responsible for planning and management of mono-centre and multicentre Clinical Studies on Cardiovascular Drugs.

Dr. Kristian Vinter Juul is Medical Science Director at Ferring Pharmaceuticals. Over the last 14 years, Dr. Juul has worked in scientific and management positions in biotech and  pharmaceutical industry. He has led the advancement of several New Chemical Entities into phase I-III and contributed with original scientific work published in peer reviewed journals and books covering a wide range of drugs and therapeutic areas.

Starting in 2001, and since 2010 being his main scientific speciality, his focus is antidiuresis therapy, including mechanism of action and clinical implications, within three major therapeutic areas: diabetes insipidus, nocturnal enuresis and nocturia – and any other abnormalities in which antidiuretic therapy may be of benefit. His main contribution to the field of science was the 2011 publication of significant gender differences in renal sentitivity to Desmopressin, a discovery with a number of clinical implications for future antidiuretic treatment

 

Antidiuresis, diabetes insipidus, nocturnal enuresis, nocturia, nocturnal polyuria, circadian control of urine production.

Marta Di Carlo was born in 1956. 1978 Degree cum laude in Biology. Training at aEMBL (European Molecular Biology Laboratory) in Heidelberg, Germany (1983-84), at SCLAVO Company in Siena (Italy) (1985-86), Biozentrum, Basel (Switzerland ). 1986 to present: Full position and Group Leader at IBIM (Institute of Biomedicine and Molecular Immunology) (NCR) Palermo Italy. Responsible for several National and International projects and component of ECC NoE (Network of Excellence). International referee for "Developmental Biology and Physiology" French Projects.  Referee for several international ISI journals. Coauthors of more than 80 papers published on ISI Journals.

Neurodegenerative process, link between neurdegenerative and metabolic diseases, drug and gene delivery, use of simple animal models for drug discovery.

Patrick Tso, PhD, has contributed significantly to understanding intestinal lipid metabolism and  diet-induced obesity. Recruited to UC in 1996, Patrick Tso and colleague David Hui, PhD, have built an outstanding Lipid Research Group, recognized for its excellence by the National Institutes of Health (NIH) through awarding of a program project grant.

Together with Stephen Woods, PhD, and Randy Seeley, PhD, Dr. Tso played an important role in establishing the Cincinnati Obesity Research Center, which was initially supported by Procter & Gamble and by an  NIH program project grant. Dr. Tso was also responsible for assembling the investigative team associated with the NIH-supported Mouse Metabolic Phenotyping Center, now in its tenth year of existence.

In November 2008, Dr. Tso took on  leadership of the Physician Scientist Training Program (PSTP).  The PSTP program enjoys  success through awards  students have acquired and  awarding three additional yearly slots for two years from the NIH.

Columbia University Medical Center, New York, USA

Dr Hu got the M.D and PhD from Shanghai second Medical University in 1973 and 1988. He worked the department of Endocrinology affiliated to University of Chicago during 1988-1990.
Dr Hu finished post doctor training in University of California during 1990-1993 and worked Department of Endocrinology at UCI as an assistant researcher from 1994 to 1996. He worked in Rui Jin Hospital affiliated to Shanghai Second Medical University during 1996-2002 as vice director of Institute of Endocrinogy of Shanghai and vice director of Department of Endocrinogy. He was promoted as a professor in 1999. He was director of Department of Endocrinology of Huashan Hospital affiliated to Fudan University and The Institute of Endocrinology and Diabetology at Fudan University during 2002-2010. Now Dr Hu is director of Institute of Endocrinology and Diabetology at Fudan University and director of Department of Endocrinology of Jinshan Hospital affiliated to Fudan Univesity.
    Dr Hu is a council member of Chinese Diabetes association and director of the study group on microvascular complication of CDS. He is  vice president of Shanghai association of diabetology. He is Editor in Chief of the Chinese edition of Diabetes Care and editorial board member Journal of Clinic Endocrinology and Metabolism and Chinese Diabetology.
   Dr Hu has finished many important research projects such as Important National Nature Science Foundation of china, National High-Tech Project of china(863), National Basic Science Project of china(973), National Nature Science Foundation of china and so on. Dr Hu has published 171 papers including JCI, Diabetes, PNAS and two books in Chinese.
 

Diabetic complications, relationship between diabetes and information
 

Yanmei  Sang graduated from Shandong Qingdao Medical college in 1991. In 2002 , she attained her MD degree from Capital Medical University. From 2006- 2007 she went to Children’s Hospital of Philadelphia, University of Pennsylvania for one year’s postdoctoral research. Her postdoctoral research subject is on mechanism of  insulin secretion. Now she is working as a chief physician and Associate Professor in Department of Endocrinology, Beijing Children’s Hospital affiliated to Capital Medical University.
 

Yanmei Sang’s main research field include type 1 diabetes, congenital hyperinsulinism and neonatal diabetes mellitus. 

Ravichandran Ramasamy is an Associate Professor at New York University, USA

Metabolic basis of ischemic injury and heart failure in diabetics.

Dr. Zhiguang Guo is Scientist of the Sanford Project at Sanford Research/USD and
Associate Professor of Pediatrics at Sanford School of Medicine in the University of South Dakota. He has profound expertise and experience in immunology, transplantation, pharmacology and diabetes. Before joining Sanford Health, he was an Assistant Professor in the Department of Surgery at the University of Minnesota and Director of Basic Research at the Diabetes Institute for Immunology and Transplantation and at the Schulze Diabetes Institute. Dr. Guo graduated from Zhongshen Medical University in China and received his Ph.D. degree in Immunology from the University of Heidelberg in Germany.
 

The current research in his laboratory is to evaluate and develop therapeutic approaches to treating T1D by ameliorating autoimmunity and promoting beta cell regeneration.

Nottingham University Hospital, Nottingham, UK

Sophie Van Linthout has completed her studies in biological engineering at the Catholic University of Leuven, Leuven, Belgium (1998) and finished her PhD in medical science, at the Catholic University of Leuven, Leuven, Belgium (2002). Here after, she was a Marie-Curie Fellow of the European Commission in Italy for 1.5 years. From 2004 on, she worked as a Post-Doc at the Department of Cardiology & Pneumology, Charité, Campus Benjamin Franklin, Berlin, Germany, where she mainly worked on finding strategies to improve diabetic cardiopathy and diabetes mellitus-associated endothelial dysfunction. Since 2009 she is a group leader at the Berlin-Brandenburg Center for Regenerative Therapies at the Charité, University of Medicine, Berlin; Germany, where she focuses her research on the experimental evaluation of cell-based strategies for cardiovascular repair

Diabetic Cardiopathy, Endothelial dysfunction, Cardiac regeneration, Mesenchymal stem cells, High-density lipoprotein

Dr. Collino was born in Italy, on 19th January 1973. Degree in Pharmaceutical Chemistry and Technology at the University of Turin, Faculty of Pharmacy, March 1998: summa cum laude. Ph. D. in “Pharmacology and Toxicology” at the University of Turin, 1998 – 2002. Visiting Scientist at The William Harvey Research Institute, Centre for Experimental Medicine, Nephrology & Critical Care, Barts and The London, Queen Mary\s School of Medicine and Dentistry, London (UK) in the years 2003-2004. Since 2002 Assistant Professor of Pharmacology, Faculty of Pharmacy, University of Turin. Member of the Italian Society of Pharmacology, the European Biomedical Research Association. , British Pharmacological Society, European Shock Society

His research activity is focused mainly on the investigation of innovative pharmacological strategies for metabolic disorders and the related cardiovascular complications